4//SEC Filing
van der Vaart Sandra D 4
Accession 0001127602-25-020493
CIK 0000920148other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 10:55 AM ET
Size
9.1 KB
Accession
0001127602-25-020493
Insider Transaction Report
Form 4
van der Vaart Sandra D
EVP, Chief Legal Officer
Transactions
- Sale
Common Stock
2025-08-13$271.42/sh−3,903$1,059,371→ 2,273.669 total - Exercise/Conversion
Common Stock
2025-08-13$131.43/sh+3,903$512,971→ 6,176.669 total - Exercise/Conversion
Non-qualified Stock Options
2025-08-13−3,903→ 0 totalExercise: $131.43From: 2020-02-12Exp: 2029-02-11→ Common Stock (3,903 underlying)
Footnotes (4)
- [F1]Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.
- [F2]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- [F3]Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
- [F4]The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.
Documents
Issuer
LABCORP HOLDINGS INC.
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001537208
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 10:55 AM ET
- Size
- 9.1 KB